CENTRO DE INMUNOLOGIA MOLECULAR

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 26229
 
  
 
C07K PEPTIDES 15121
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0317,674 CONJUGATE COMPRISING ERYTHROPOIETIN AND A BRANCHED POLYMER STRUCTUREJan 08, 15Nov 03, 16[A61K]
2016/0166,667 DIVALENT VACCINE COMPOSITIONS AND THE USE THEREOF FOR TREATING TUMORSAug 01, 14Jun 16, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9790279 Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)Dec 04, 12Oct 17, 17[A61K, C07K]
9701730 TGFβ-derived polypeptides and uses thereofOct 30, 13Jul 11, 17[A61K, C07K]
9670285 Monoclonal antibody and a method thereofDec 15, 15Jun 06, 17[A61K, C07K]
9527920 Recombinant antibodies having dual specificity for gangliosides and use thereofFeb 21, 13Dec 27, 16[A61K, C07K]
9206243 IL-2 derivative polypeptidesNov 10, 11Dec 08, 15[A61K, C07K]
8841251 Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumorsJan 10, 12Sep 23, 14[A61K, A61P, C07K]
8778879 Homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumorsJun 26, 08Jul 15, 14[A61K, A61P, C07K]
8758753 Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumorsMar 19, 09Jun 24, 14[A61K, C12N, G01N, C07K]
8759486 Immunomodulatory interleukin-2 polypeptides and methods of treating melanomaNov 26, 10Jun 24, 14[A61K, C07K]
8591917 Ganglioside based vaccine compositions for subcutaneous administrationFeb 27, 04Nov 26, 13[A61K, C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0024,220 PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CD6 MONOCLONAL ANTIBODY USED IN THE DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITISAbandonedApr 14, 14Jan 28, 16[A61K, C07K]
2010/0047,207 Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor AntibodiesAbandonedSep 27, 07Feb 25, 10[A61K]
2006/0036,082 Method of obtaining cell lines in a protein-free medium and cell lines thus obtainedAbandonedOct 22, 03Feb 16, 06[C12N, C07K]
6891023 Antibodies and Fv fragment recognizing antigen IOR C2ExpiredNov 16, 00May 10, 05[C07K]
2005/0069,535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosidesAbandonedOct 25, 04Mar 31, 05[A61K]
2004/0253,233 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumorsAbandonedNov 17, 03Dec 16, 04[A61K]
2003/0054,011 Vaccine composition containing transforming growth factor alpha (TGFalpha). it use in malignant diseases therapyAbandonedDec 06, 01Mar 20, 03[A61K, C12P, C12N, C07K]
2002/0160,014 Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activityAbandonedDec 07, 01Oct 31, 02[A61K, C12N, C07K]
6433148 Monoclonal anti-idiotypic antibodies (AB2) and their usesExpiredNov 17, 97Aug 13, 02[C12P, C07K]
5894018 Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivative thereof having anti-tumor activity and use thereof in the therapy of malignant diseasesExpiredFeb 21, 96Apr 13, 99[A61K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.